Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Brain Neoplasms × Levetiracetam × Clear all

Phase

Status

Completed 3 Recruiting 2 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Seizures 1 Postoperative Seizures After Brain Tumor Surgery 1 Brain Neoplasms 1

Interventions

aflutinib 3 Radiotherapy 3 Blood Specimen Collection 3 Bevacizumab 3 Surveys and Questionnaires 2 Radiosurgery 2 Magnetic Resonance Spectroscopy 2 Indocyanine Green 2 Cyclophosphamide 2 Biopsy 2 Aminolevulinic Acid 2 trastuzumab deruxtecan 1 tovorafenib 1 sacituzumab govitecan 1 posaconazole 1 pembrolizumab 1 peginterferon alfa-2b 1 osimertinib 1 neratinib 1 montelukast 1 lorlatinib 1 gallium maltolate 1 fludarabine 1 contrast agent BR1 1 asciminib 1 anlotinib 1 Watchful Waiting 1 Vitamin B 6 1 Valganciclovir 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05897658 2024-10-23

LeviTaTe Pilot

Hamilton Health Sciences Corporation

Phase 3 Not yet recruiting

Brain Neoplasms, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡